The main objective is to develop and validate new endothelial function markers discriminating and reproducible by assessing the ability to reveal changes in endothelial function in response to positive and negative nutritional stimuli.
The study will be randomized (on the order of taking the products: a single dose of lipids or a single dose of flavonoids), single-blinded, cross-over for each population (healthy and metabolic syndrome).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
50
CHU de Clermont-Ferrand
Clermont-Ferrand, France
Flow Mediated Dilatation (FMD)compared to hyperemic velocity time integral (VTI) and endothelial microparticles (MPE)
Changes in endothelial function from baseline at 150 mn after the product intake, evaluated by: \- Flow Mediated Dilatation (FMD) (reference) Compared to: * Hyperemic Velocity Time Integral (VTI) * Endothelial microparticles (MPE)
Time frame: at 150 mn after the product intake
Changes in endothelial function evaluated by cell adhesion molecule (CAM) and micro-RNA (miRNA)
Changes in endothelial function from baseline at 150 mn after the product intake, evaluated by: * Cell Adhesion Molecule (CAM) * Micro-RNA (miRNA)
Time frame: at 150 mn after the product intake
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.